- Patent Title: Binding domain or antibody specific to a human serum albumin (HSA)
-
Application No.: US16098085Application Date: 2017-04-28
-
Publication No.: US11466076B2Publication Date: 2022-10-11
- Inventor: Ralph Adams , Sam Philip Heywood
- Applicant: UCB BIOPHARMA SPRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SPRL
- Current Assignee: UCB BIOPHARMA SPRL
- Current Assignee Address: BE Brussels
- Agency: Medler Ferro Woodhouse & Mills
- Priority: GB1607636 20160501,GB1607828 20160504
- International Application: PCT/EP2017/060266 WO 20170428
- International Announcement: WO2017/191062 WO 20171109
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/18 ; C07K14/76 ; C07K14/765 ; C07K16/06 ; A61K39/395 ; A61K39/00 ; C07K16/46
Abstract:
The present disclosure relates to a method of modulating the half-life of a binding domain specific to a serum carrier protein by mutating the sequence and a modulated binding domain specific to a serum carrier protein.
Public/Granted literature
- US20190144529A1 AFFINITY ENGINEERED SERUM PROTEIN CARRIER BINDING DOMAIN Public/Granted day:2019-05-16
Information query
